Breaking News
Sort by:
Top Post
Roche’s Tecentriq Plus Avastin Reduced Risk of Cancer Returning in People with Certain Types of Adjuvant Liver Cancer in a Phase III Study
Roche has announced new data from the Phase III IMbrave050 study that show Tecentriq (atezolizumab) […]
Tollys Releases New Preclinical Data Demonstrating Lifelong Potent Anti-tumor Immunity of TL-532
Tollys, a biopharmaceutical company developing TL-532, the first anti-cancer immunotherapy based on a new generation […]
Transcenta Announces Global Clinical Collaboration with Bristol Myers Squibb to Evaluate TST001 in Combination with Opdivo® in Patients with Locally Advanced or Metastatic Gastric / Gastroesophageal Junction Cancer
Transcenta Holding Limited (“Transcenta”) (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in […]
Compugen's Computational Discovery Leverages Single Cell Spatial Transcriptomics to Gain In-Depth Understanding of the Tumor Microenvironment
Compugen Ltd. (Nasdaq: CGEN), (“Compugen,” the “Company”), a clinical-stage cancer immunotherapy company and a pioneer in computational […]
SomaLogic to Provide 210 Million Protein Measurements to EPIC Researchers to Better Understand and Predict Cancer Development
SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that the company will […]
NHS Fast Tracks New ‘Gamechanging’ Drug for Lung Cancer
A targeted new drug for a rare and aggressive form of lung cancer will be […]
Sanofi and Seagen Announce Collaboration to Develop and Commercialize Multiple Novel Antibody-drug Conjugates
Sanofi and Seagen Inc. (Nasdaq:SGEN) today announced an exclusive collaboration agreement to design, develop, and commercialize antibody-drug conjugates […]
Life-extending Injection for Blood Cancer Available on the NHS
A life-extending injection for a fatal form of blood cancer will be available to around […]
Impact Therapeutics Announces Completion of Series D1 Financing
IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development of targeted anti-cancer therapeutics […]
Curebase and Blue Note Therapeutics Collaborate on Home-based Clinical Trial of Prescription Digital Therapeutics to Help People with Cancer Manage their Health
Curebase, a company committed to democratizing access to clinical studies, and Blue Note Therapeutics, a prescription […]
Domain Therapeutics and Explicyte Enter Partnership Agreement in Immuno-oncology
Domain Therapeutics, a biopharmaceutical company specializing in the discovery and development of new drugs targeting […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more